Mode
Text Size
Log in / Sign up
N/A N=149 Randomized Single-blind Prevention

The Efficacy of Individualized Dietary Advice in Improving Diet Quality and Cardiovascular Health

Cardiovascular Diseases

Enrolled (actual)
149
Serious AEs
0.0%
Results posted
Aug 2025
Primary outcome: Primary: Difference in Mean Change in Prime Diet Quality Score Between Groups Between Months 0 and 6 — 1.22 Units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Personalised dietary advice and educational material (Behavioral); Educational material (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Queen's University, Belfast
Primary completion
Mar 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Difference in Mean Change in Prime Diet Quality Score Between Groups Between Months 0 and 6
1.22
SECONDARY
Alcohol Consumption
SECONDARY
Medication Use
SECONDARY
Physical Activity
SECONDARY
Anthropometric Data - Weight
SECONDARY
Anthropometric Data - Waist to Hip Ratio
SECONDARY
Anthropometric Data - Height
SECONDARY
Anthropometric Data - Body Composition.
SECONDARY
Blood Pressure
SECONDARY
Biomarkers of Cardiometabolic Risk
SECONDARY
Biomarkers of Diet Quality
SECONDARY
Gut Microbiota Composition (Subset of Participants Only)

Summary

This study is a a randomized controlled parallel group dietary intervention conducted over six months in participants at high risk of cardiovascular disease living in Ireland (North and South) to evaluate the efficacy of individualized dietary advice incorporating biomarker profiles in improving diet quality and cardiometabolic outcomes.

Eligibility Criteria

Participants will be at high risk (>20% over 10 years) of developing CVD.

Inclusion Criteria

Participants will be considered eligible to enroll in the study if they are:

  • overweight (BMI >27 and ≤ 45 kg/m2),
  • have low Prime Diet Quality Score (PDQS 28 Units/week for men or >21 Units/week for women),
  • have a low predicted likelihood to change dietary habits
  • are unable to provide informed consent.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03854461). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search